Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC Webinar: Market Access Attractiveness Index for IVD Tests: Which European Markets Offer the Best Opportunities?

The European market access environment for in-vitro diagnostic (IVD) tests varies substantially between countries. Differences in reimbursement mechanisms, laboratory funding, health technology assessment (HTA), and market access pathways create different opportunities and barriers for manufacturers. Understanding these differences is essential for effective market prioritization and European commercialization strategies.

MTRC invites IVD industry professionals to an online seminar introducing the Market Access Attractiveness Index (MAAI) for IVD tests, a structured approach to comparing European markets from a market access perspective. Based on MTRC's recent White Paper, the seminar will explore how differences between national reimbursement and funding systems influence the attractiveness of individual markets and what these findings mean for IVD manufacturers.

During the seminar, we will discuss:

  • The key factors determining market access attractiveness for IVD tests in Europe;
  • How reimbursement mechanisms and laboratory funding models differ across European countries;
  • The methodology and key dimensions of the Market Access Attractiveness Index (MAAI);
  • How European countries compare in terms of market access attractiveness for IVD tests;
  • The main opportunities and barriers in individual European markets;
  • How IVD manufacturers can use the findings to inform country prioritization, reimbursement strategy, and European launch planning.

The seminar will be particularly relevant to professionals working in Market Access, Reimbursement, Health Economics and Outcomes Research (HEOR), Commercial Strategy, Business Development, Marketing, Portfolio Management, and European launch planning within the IVD industry.

Speaker: Dr Oleg Borisenko, Founder and Director of MTRC

Date and time: 17.00 CET, January 21, 2027

Format: Online seminar. The seminar will not be recorded.

Participation: Only representatives of the medical technology and IVD industry.

Registration: link.